Proteon Therapeutics Inc (PRTO): Flynn’s Purchasing RaceBy Jodor JalitOctober 28, 2014 James E. Flynn, a large shareholder at Proteon Therapeutics Inc (NASDAQ:PRTO) disclosed today the acquisition of 1,255,107 shares of common…